Interleukin-10 Inhibits Postinjury Tumor Necrosis Factor-Mediated Human Vascular Smooth Muscle Proliferation
- 31 December 1998
- journal article
- Published by Elsevier BV in Journal of Surgical Research
- Vol. 80 (2), 352-356
- https://doi.org/10.1006/jsre.1998.5486
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Plasma levels of immunoinhibitory cytokines interleukin-10 and transforming growth factor-β in patients undergoing coronary artery bypass graftingEuropean Journal of Cardio-Thoracic Surgery, 1997
- Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1996
- LOCAL PRODUCTION OF CYTOKINES IN THE HUMAN CARDIAC ALLOGRAFTTransplantation, 1994
- Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytesEuropean Journal of Immunology, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Tumour necrosis factor-a can modulate the phenotype of aortic smooth muscle cellsScandinavian Journal of Clinical and Laboratory Investigation, 1993
- Macrophage deactivation by interleukin 10.The Journal of Experimental Medicine, 1991
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991
- Detection and localization of tumor necrosis factor in human atheromaThe American Journal of Cardiology, 1990
- Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells.The Journal of Experimental Medicine, 1987